Prospective Evaluation of PRP and BMC Treatment to Accelerate Healing After ACL Reconstruction

NCT04205656 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

BIOLOGICAL: Leukocyte-Poor Platelet Rich Plasma (LP-PRP)
BIOLOGICAL: Bone Marrow Concentrate (BMC)
OTHER: Control group (Placebo)

Sponsor

Steadman Philippon Research Institute

Collaborators

[object Object]
[object Object]